| 中文名称 | 普罗加比 |
| 英文名称 | Progabide |
| CAS号 | 62666-20-0 |
| 分子式 | C17H16ClFN2O2 |
| 分子量 | 334.77 |
| EINECS号 | 263-679-4 |
| 熔点 | 133-135°; mp 142.5° (Kaplan, J. Med. Chem.) |
| 沸点 | 525.4±50.0 °C(Predicted) |
| 密度 | 1.2822 (estimate) |
| 溶解度 | 氯仿(微溶超声处理)、DMSO、甲醇(微溶超声处理) |
| 形态 | 固体 |
| 酸度系数(pKa) | pKa 3.41 ± 0.04(0.4% MeOH,t=37,Iundefined)(Approximate) |
| 颜色 | 浅黄色至厚黄色 |
| 水溶解性 | 37.16mg/L(37 ºC) |
| 毒性 | LD50 i.p. in mice: 900 mg/kg (Kaplan) |
GABA receptor
Progabide is a gamma-aminobutyric acid receptor (GABA) agonist. Doses of 50, 100 and 200 mg/kg Progabide given IP to male Wistar rats increase the plasma corticosterone levels by 244, 365 and 476% respectively (t=6.44 to12.55, p<0.01). 10 mg/kg of Progabide fails to change the concentration of corticosterone in plasma (t=0.76, N.S.). The increased plasma corticosterone level induced by administration of 200 mg/kg Progabide is evident 30 (t=2.625, p<0.05), 60 (t=13.13, p<0.001) and 120 min (t=4.07, p<0.01) after drug injection, but returns to the control value 240 min after drug injection (t=0.86, N.S.). The greatest corticosterone rise (compare with the corresponding control) is reached 60 min following the administration of Progabide.